Navigation Links
BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
Date:5/1/2008

BIRMINGHAM, Ala., May 1 /PRNewswire-FirstCall/ -- BioCryst Pharmaceuticals (Nasdaq: BCRX) today announced that its first quarter 2008 financial results will be released on Thursday, May 8, 2008. At 8:30 a.m. Eastern Time BioCryst will host a conference call and webcast to discuss the financial results and provide an update on the Company's programs and further clinical data. The call will be led by Jon P. Stonehouse, BioCryst's Chief Executive Officer, and Stuart Grant, BioCryst's Chief Financial Officer.

The webcast can be accessed by logging onto http://www.biocryst.com. Please connect to the website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. To participate in the conference call, please dial 1-800-860- 2442 (U.S.). The audio portion of the webcast will be archived and available for replay for 14 days.

About BioCryst

BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The Company is advancing multiple internal programs toward potential commercialization including forodesine HCl in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life-threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization of BCX-4208, and is collaborating with Mundipharma for the development and commercialization of forodesine HCl in markets across Europe, Asia, Australia and certain neighboring countries. In January 2007, the U.
'/>"/>

SOURCE BioCryst Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...re-USNewswire/ -- ,, Expert Panel to Discuss ..., A special press briefing will be held Wednesday,...ng a panel of top experts who will discuss the rec...elease of revised screening mammography guidelines...experts and government authorities dispute the gui...
(Date:12/2/2009)...cal Products Inc., an industry leader in healthcar...ces the opening of its new headquarters in the Irv...Research Drive, Irvine, California 92618. In addit...he Irvine Spectrum plus an assembly and distributi...t expansion reflects Links Medical,s rapid growth ...
(Date:12/2/2009)...firm prevails in counterclaim against three plaint...of business dispute over work done on hotel constr...Fla. (Lexis Nexis) December 2, 2009 -- The Tampa-b... completed the settlement of a two-year legal disp...,s client, ConArt, Inc., , ,ConArt, a Georgia-base...
(Date:12/2/2009)...Dec. 1 Last month on a prominent n..., Associate Professor at the Stanford Sleep Disord...ne, recommended the Ecotones Duet Sleep Sound Mach...ing to achieve a better night,s sleep with minimal...m for people when they are sleeping," said Dr. Pel...
(Date:12/2/2009)...ire-USNewswire/ -- Targeted breast ultrasound of s... a safe, reliable and cost-effective alternative t...ing to the findings of two studies presented today... of North America (RSNA). ,, "By performing hig...ber of expensive and avoidable invasive diagnostic...
Breaking Medicine News(10 mins):Health News:Wednesday, Dec. 2: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Health News:Wednesday, Dec. 2: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3Health News:Gallagher Keenan Obtains $500,000 Settlement for ConArt, Inc. in Dispute with Florida Hotel Companies 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 3Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2
...of global warming keeps coming up from across the ...oxic Californian// seawaters are killing marine li...ues to wreak havoc. A couple of days ago it was re...cliffs) is ice-free and snow bunting birds have mi...
...w coming of age and reaching sexual maturity. Girl...encing a higher number than// expected of cervical... monitored the rate of first-time pregnancies, gen...had abnormal cervical cells. “We have already ...
...iences enthralled as spiritual counselor Sadguru J...ppiness and peace. Far from being a moral sc...discourse late Thursday on 'Circus of the mind' wa... which has a thousand neurons shooting messages to...
... higher the MRSA infection rate, research from// t...led. The impact of risk management standard...tals study looked at how demanding risk management... Institutions with the highest number of 'bed...
...olved. The nature of dying is not medical, it is e...xperience, not a set of medical problems to be sol...ll or the old and infirm, who are approaching the ...ed of pain and symptoms of the ailment, so as to e...
...y resuscitation (CPR) as well as adults, finds a s...gest that children as young as nine years old shou...ns. Bystander CPR more than doubles the chan... demanding. The ‘Heartstart Schools’ traini...
Other Medicine News:Health News:Norwegian Glacier Shrinks and Marine Life Poisoned as the Globe Warms 2Health News:Norwegian Glacier Shrinks and Marine Life Poisoned as the Globe Warms 3Health News:Mind Control is the Key to Happiness: Sadguru Jaggi Vasudev 2Health News:Better Risk Management Could Cut MRSA Infection Rates 2Health News:Elevate End- Of- Life Experience by Enhancing Quality of Hospice Care 2
(Date:12/1/2009)... , NEW YORK, Dec. 1 Re...h report is available in its catalogue: ,, Mol... http://www.reportlinker.com/p0164231/Molecular-Di...cular diagnostics market is being driven by severa...ed and easy-to-handle techniques, which combine op...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Re...h report is available in its catalogue: ,, Con... of Market Trends & Opportunities ,, http...-Outsourcing-CRO---A-Global-Update-of-Market-Trend...sourcing (CRO), which came into being in the seven...
(Date:12/1/2009)... , NEWNAN, Ga., Dec. 1 ...ty surface treatments for medical devices and of s...en, MD, FACR, FACC, FSCAI, founder and medical dir...in Miami, Florida, will discuss the CATANIA(TM) St...nnovations in Cardiovascular Interventions Confere...
Breaking Medicine Technology:Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6Reportlinker Adds Molecular Diagnostics - A World Market Review 7Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 8Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Elderplan Opts for Care to Cares Radiology Network 57373 1Elderplan Opts for Care to Cares Radiology Network 57373 2IH Systems RIVA Top Pick for Directors of Pharmacy 57370 1IH Systems RIVA Top Pick for Directors of Pharmacy 57370 2Jumpstart Medicine Opens Two New Locations in San Francisco 57367 1Jumpstart Medicine Opens Two New Locations in San Francisco 57367 2Jumpstart Medicine Opens Two New Locations in San Francisco 57367 3
...nesday,s Satellite Symposium,3: The Challenges of ...e,International Society of Heart and Lung Transpla...ns, clinicians and researchers discussed some of,t...ransplant outcomes in,patients with CF., A highli...holderia,Cenocepacia is an Absolute Contradiction ...
...ed at the Upcoming ECCMID Conference, REINACH, Sw...published on 9 April, Arpida Ltd. (SWX: ARPN) toda...inical programme with,intravenous iclaprim in comp.... Extensive data on ASSIST-1 has been presented at...ST-2 will be presented at the upcoming 18th,Europe...
Other Medicine Technology:Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting 2Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting 3Arpida Provides Further Comments on the Pivotal Phase III Trials 2Arpida Provides Further Comments on the Pivotal Phase III Trials 3Arpida Provides Further Comments on the Pivotal Phase III Trials 4
...c has been a key participant in the area of blood ...us Medtronic autotransfusion systems allowed clini...latelets, as well as to determine requirements for...ch plasma (PRP) for a small amount of autologous b...
RX HERCULINK® PLUS Biliary Stent System
Response Catheter
Fast-Cath™ Guiding Introducers
Medicine Products: